Primary |
Contraception |
58.4% |
Product Used For Unknown Indication |
13.6% |
Oral Contraception |
5.2% |
Dysmenorrhoea |
2.0% |
Maternal Exposure During Pregnancy |
2.0% |
Acne |
1.6% |
Endometriosis |
1.6% |
Menorrhagia |
1.6% |
Menstruation Delayed |
1.6% |
Polycystic Ovaries |
1.6% |
Urinary Tract Infection |
1.6% |
Arthralgia |
1.2% |
Liver Disorder |
1.2% |
Menstrual Cycle Management |
1.2% |
Menstrual Disorder |
1.2% |
Psoriatic Arthropathy |
1.2% |
Amenorrhoea |
0.8% |
Depression |
0.8% |
Drug Use For Unknown Indication |
0.8% |
Dyspnoea |
0.8% |
|
Pulmonary Embolism |
13.2% |
Vomiting |
7.9% |
Hypothyroidism |
6.6% |
Vaginal Haemorrhage |
6.6% |
Amenorrhoea |
5.3% |
Crohn's Disease |
5.3% |
Deep Vein Thrombosis |
5.3% |
Breast Mass |
3.9% |
Caesarean Section |
3.9% |
Drug Dose Omission |
3.9% |
Drug Interaction |
3.9% |
Enteritis |
3.9% |
Inappropriate Schedule Of Drug Administration |
3.9% |
Leiomyoma |
3.9% |
Malaise |
3.9% |
Maternal Exposure During Pregnancy |
3.9% |
Nephrolithiasis |
3.9% |
Pregnancy On Oral Contraceptive |
3.9% |
Pulmonary Thrombosis |
3.9% |
Aneurysm |
2.6% |
|
Secondary |
Contraception |
44.4% |
Product Used For Unknown Indication |
9.5% |
Menorrhagia |
9.0% |
Depression |
4.2% |
Anxiety |
3.7% |
Psoriatic Arthropathy |
3.7% |
Oral Contraception |
3.2% |
Attention Deficit/hyperactivity Disorder |
2.6% |
Back Pain |
2.6% |
Depressive Symptom |
2.1% |
Immunodeficiency Common Variable |
2.1% |
Phobia Of Flying |
2.1% |
Acne |
1.6% |
Arthralgia |
1.6% |
Convulsion |
1.6% |
Menstrual Disorder |
1.6% |
Cerebral Vasoconstriction |
1.1% |
Essential Hypertension |
1.1% |
Multiple Sclerosis |
1.1% |
Prophylaxis |
1.1% |
|
Myocardial Infarction |
8.5% |
Weight Increased |
8.5% |
Angiomyolipoma |
6.4% |
Deep Vein Thrombosis |
6.4% |
Hypoaesthesia |
6.4% |
Ischaemic Stroke |
6.4% |
Back Pain |
4.3% |
Cholecystectomy |
4.3% |
Drug Interaction |
4.3% |
Intracranial Venous Sinus Thrombosis |
4.3% |
Menorrhagia |
4.3% |
Normal Newborn |
4.3% |
Peritoneal Haemorrhage |
4.3% |
Pregnancy |
4.3% |
Pregnancy On Oral Contraceptive |
4.3% |
Pulmonary Embolism |
4.3% |
Thrombosis |
4.3% |
Visual Disturbance |
4.3% |
Withdrawal Bleed |
4.3% |
Anaemia |
2.1% |
|
Concomitant |
Contraception |
19.1% |
Product Used For Unknown Indication |
15.1% |
Drug Use For Unknown Indication |
7.7% |
Acne |
6.2% |
Psoriasis |
6.0% |
Crohn's Disease |
4.4% |
Depression |
4.4% |
Multiple Sclerosis |
4.2% |
Rheumatoid Arthritis |
4.2% |
Pneumonia |
3.3% |
Menstrual Cycle Management |
2.9% |
Anxiety |
2.7% |
Oral Contraception |
2.7% |
Pain |
2.7% |
Premenstrual Syndrome |
2.7% |
Tuberous Sclerosis |
2.7% |
Asthma |
2.6% |
Smoking Cessation Therapy |
2.6% |
Prophylaxis Against Transplant Rejection |
2.2% |
Hypertension |
1.6% |
|
Vomiting |
15.4% |
Deep Vein Thrombosis |
8.8% |
Blood Immunoglobulin M Decreased |
7.7% |
Overdose |
6.6% |
White Blood Cell Count Increased |
5.5% |
Cholelithiasis |
4.4% |
Injury |
4.4% |
Pulmonary Embolism |
4.4% |
Speech Disorder |
4.4% |
Suicidal Ideation |
4.4% |
Vaginal Haemorrhage |
4.4% |
Anxiety |
3.3% |
Complication Of Pregnancy |
3.3% |
Injection Site Swelling |
3.3% |
Intracranial Tumour Haemorrhage |
3.3% |
Ischaemic Stroke |
3.3% |
Liver Function Test Abnormal |
3.3% |
Pain |
3.3% |
Pain In Extremity |
3.3% |
Progressive Multifocal Leukoencephalopathy |
3.3% |
|
Interacting |
Contraception |
28.6% |
Attention Deficit/hyperactivity Disorder |
14.3% |
Anxiety |
10.7% |
Arthralgia |
10.7% |
Psoriatic Arthropathy |
10.7% |
Pollakiuria |
7.1% |
Product Used For Unknown Indication |
7.1% |
Discomfort |
3.6% |
Myoclonic Epilepsy |
3.6% |
Oral Contraception |
3.6% |
|
Drug Interaction |
15.4% |
Maternal Exposure During Pregnancy |
15.4% |
Withdrawal Bleed |
15.4% |
Abdominal Pain |
7.7% |
Ovarian Cyst Ruptured |
7.7% |
Peritoneal Haemorrhage |
7.7% |
Pregnancy On Oral Contraceptive |
7.7% |
Tremor |
7.7% |
Vaginal Haemorrhage |
7.7% |
Visual Disturbance |
7.7% |
|